Viemed Healthcare, Inc. (VMD)

In the past six months, Viemed's stock was impacted by several events. The company announced its Q1 2026 financial results, reporting revenue growth but a stock decline due to missed EPS estimates. Viemed announced record 2025 financial results and a share repurchase program. The company presented at investor conferences and updated its full-year 2026 guidance. The stock's 52-week range was $5.93 to $10.18, and the stock price as of April 30, 2026, was $9.96 per share.

Viemed Healthcare, Inc. experiences predictable seasonal patterns in its demand and financial performance. The first quarter typically carries a seasonal pattern, with Q1 adjusted EBITDA margins being lower than full-year margins. Sequential growth is generally expected in the second half of the year.

Viemed Healthcare, Inc. operates in the Healthcare sector, focusing on respiratory disease management solutions, particularly for COPD and chronic respiratory failure. The company provides respiratory disease management through non-invasive ventilation and other therapies. They sell and rent home medical equipment (HME) devices, including ventilators and oxygen concentrators. Viemed offers sleep apnea management solutions and equipment, as well as in-home sleep apnea testing services. They also provide neuromuscular care, oxygen therapy services, maternity and women's health products, and healthcare staffing and recruitment services.

Viemed Healthcare, Inc. has a national presence, serving over 50,000 active patients across all 50 states in the United States. The company is headquartered in Lafayette, Louisiana.

Viemed Healthcare, Inc. has generally maintained a positive brand image, emphasizing its role as a leader in technology-enabled post-acute respiratory care and its commitment to improving patient outcomes. The company highlights its "high-touch, high-tech" care model. No significant negative events or controversies specifically impacting Viemed Healthcare, Inc.'s brand reputation in the past year were found.

Viemed Healthcare, Inc. is primarily owned by institutional shareholders (61.73%), followed by retail investors (24.43%), and company insiders (13.83%). Major institutional owners include BlackRock, Inc., Forager Capital Management, LLC, and Vanguard Group Inc. The largest individual shareholder is Casey Hoyt, who owns 6.05% of the company.